Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?
Metabolic dysfunction-associated steatotic liver disease (MASLD) closely associates with obesity and type 2 diabetes. Lifestyle intervention and bariatric surgery aiming at substantial weight loss are cornerstones of MASLD treatment by improving histological outcomes and reducing risks of comorbidit...
保存先:
主要な著者: | , , |
---|---|
フォーマット: | Artigo |
言語: | 英語 |
出版事項: |
2024
|
オンライン・アクセス: | https://doi.org/10.1016/j.metabol.2024.155937 |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|